Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 35% ± 11% | |
lung | 14 studies | 28% ± 17% | |
intestine | 9 studies | 23% ± 7% | |
kidney | 5 studies | 28% ± 8% | |
bone marrow | 5 studies | 24% ± 8% | |
lymph node | 5 studies | 32% ± 4% | |
liver | 5 studies | 31% ± 9% | |
thymus | 3 studies | 53% ± 23% | |
breast | 3 studies | 22% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 818.84 | 653 / 653 | 100% | 102.19 | 603 / 605 |
lung | 100% | 895.97 | 576 / 578 | 99% | 140.47 | 1148 / 1155 |
breast | 100% | 644.35 | 458 / 459 | 99% | 133.07 | 1105 / 1118 |
intestine | 98% | 1149.24 | 943 / 966 | 99% | 147.92 | 524 / 527 |
bladder | 95% | 678.29 | 20 / 21 | 100% | 160.06 | 502 / 504 |
skin | 100% | 892.35 | 1802 / 1809 | 94% | 66.45 | 443 / 472 |
prostate | 98% | 506.91 | 239 / 245 | 95% | 59.86 | 475 / 502 |
stomach | 94% | 657.61 | 338 / 359 | 98% | 122.21 | 280 / 286 |
uterus | 92% | 412.43 | 157 / 170 | 99% | 126.89 | 453 / 459 |
kidney | 100% | 1312.51 | 89 / 89 | 90% | 55.49 | 808 / 901 |
esophagus | 88% | 615.36 | 1274 / 1445 | 100% | 99.16 | 183 / 183 |
pancreas | 89% | 308.88 | 291 / 328 | 96% | 85.30 | 170 / 178 |
liver | 98% | 914.86 | 222 / 226 | 50% | 23.70 | 204 / 406 |
ovary | 34% | 87.95 | 61 / 180 | 97% | 77.92 | 418 / 430 |
adrenal gland | 74% | 200.15 | 190 / 258 | 54% | 23.01 | 125 / 230 |
brain | 75% | 382.20 | 1987 / 2642 | 42% | 18.16 | 298 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 220.70 | 29 / 29 |
spleen | 100% | 2399.64 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 126.51 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 50.06 | 1 / 1 |
peripheral blood | 99% | 1783.37 | 923 / 929 | 0% | 0 | 0 / 0 |
adipose | 99% | 573.44 | 1190 / 1204 | 0% | 0 | 0 / 0 |
heart | 81% | 245.63 | 697 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 80% | 318.99 | 1073 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 63% | 26.04 | 50 / 80 |
muscle | 3% | 5.44 | 23 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032970 | Biological process | regulation of actin filament-based process |
Gene name | ABRACL |
Protein name | ABRA C-terminal like Costars family protein ABRACL (ABRA C-terminal-like protein) |
Synonyms | PRO2013 HSPC280 C6orf115 |
Description | |
Accessions | ENST00000367660.4 Q9P1F3 Q5SZC9 ENST00000461027.1 |